AMRI has extended a key insourcing relationship with a major pharmaceutical company aimed at accelerating their chemistry and drug discovery efforts. The insourcing collaboration began in 2011 and is being extended from its original termination date of December 2018 to December 2021. Details were not disclosed. “Insourcing relationships provide the benefit of accelerating drug discovery, drug product and manufacturing efforts by maximizing the real-time exchange of scientific informati...